Vinay Prasad, an oncologist and epidemiologist known for his critical take on pharmaceutical regulation, talks about the troubling approval of expensive drugs with minimal benefits. He dives into how profit motives skew oncology drug development and critiques the FDA's shift towards less public health protection. Prasad highlights the ethical dilemmas in healthcare, particularly regarding elderly care, and laments the decline of personal duty in society. His insights urge a reevaluation of what truly matters in healthcare and patient outcomes.